Delhi has so far recorded 472 cases in November, 2,431 in October, 1,052 in September, 256 in August and 76 in July ...

MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced financial and operational results for the third quarter ended September 30, ...

Inovio Pharmaceuticals ( INO -3.64%) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...

International Assets Investment Management LLC raised its stake in Vector Group Ltd. (NYSE:VGR – Free Report) by 2,284.9% ...

DENGUE cases in Cebu City are on a downward trend following a peak in early September, according to Mayor Raymond Alvin Garcia. The total reported cases reached ...

Today, per Deadline, the company rolled out its “GO Plan” (short for “go on offense”), a series of improvements to seating, ...

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported third quarter results and business highlights for the quarter ended September 30, 2024, including recent commercial ...

RJVA-002 is a locally administered AAV9 viral vector that expresses human GIP and GLP-1 ... Research and development expense was $19.0 million for the quarter ended September 30, 2024, compared to ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

Q3 2024 Earnings Call Transcript November 8, 2024 Amneal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

High dose TSHA-102 was generally well tolerated with no SAEs or DLTs in two adolescent/adult patients and one <a target=_blank href= ...

Good afternoon, everyone, and thank you for joining the Lumen Technologies third quarter 2024 earnings call. On the call to ...